Back to today’s briefing

Story perspectives

New AI-Driven Therapy Aims to Revolutionize Malaria Treatment

7/25/2025

50 8

Summary

Story summary

Eyam Health has joined forces with Medicines for Malaria Venture to revolutionize malaria treatment with a groundbreaking monoclonal antibody therapy. Leveraging Eyam's innovative AI-driven Jennerator platform, they aspire to deliver a single-dose solution for under CAD$1, targeting resource-poor regions and paving the way for affordable, effective malaria prevention.

1 of 1

Story summary

Eyam Health has joined forces with Medicines for Malaria Venture to revolutionize malaria treatment with a groundbreaking monoclonal antibody therapy. Leveraging Eyam's innovative AI-driven Jennerator platform, they aspire to deliver a single-dose solution for under CAD$1, targeting resource-poor regions and paving the way for affordable, effective malaria prevention.